EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with gemcitabine/nab-paclitaxel for the first-line treatment of metastatic PDAC, including sample size ...
GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, today announced that the U.S. Food and Drug Administration (FDA) has cleared ...
The US Food and Drug Administration (FDA) has cleared GenEditBio Limited’s Investigational New Drug (IND) application to ...
TipRanks on MSN
Theriva Biologics gains EMA backing for VCN-01 phase 3
Theriva Biologics ( ($TOVX) ) just unveiled an update. On December 29, 2025, Theriva Biologics reported that it received positive Scientific ...
Finnish eyewear company IXI is gearing up to launch smart glasses that look just like ordinary spectacles, but are able to “autofocus” based on the perceived needs of the wearer.
BostonGene, the developer of the leading AI foundation model for tumor and immune biology, today announced a strategic collaboration with AstraZeneca, a global, science-led biopharmaceutical company ...
An update from Pharmaust Limited ( ($AU:NUZ) ) is now available. Neurizon Therapeutics has provided a regulatory update on NUZ-001, its ...
New members bring deep experience in pancreatic, colorectal, and anal cancers to guide pelareorep’s development as a platform immunotherapy across GI tumorsCompany continues to strengthen its clinical ...
Find Heart Tracking Latest News, Videos & Pictures on Heart Tracking and see latest updates, news, information from NDTV.COM. Explore more on Heart Tracking.
Detailed price information for Os Therapies Incorporated (OSTX-A) from The Globe and Mail including charting and trades.
Detailed price information for Werewolf Therapeutics Inc (HOWL-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback